Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 31, 2008

Investigators Reveal HTLV-1’s Mechanism for Inducing Leukemia/Lymphoma

  • A reduction in histone protein levels is linked to T-lymphotropic virus type-1 (HTLV-1) infection and the development of cancer, according to Colorado State University investigators. HTLV-1 is a retrovirus that causes adult T-cell leukemia/lymphoma (ATLL).

    A single protein made by the virus, Tax, is reportedly thought to be enough to trigger cancer development. Tax has a number of effects in the cell, including promoting inappropriate cell division, repressing DNA repair mechanisms, and causing genomic instability.

    The investigators discovered that the levels of histone proteins and histone transcripts were lower in T-cell lines infected with HTLV-1 than in uninfected cell lines. They also showed that Tax could cause a drop in the levels of histone transcript in uninfected cells.

    Histone proteins are required for the packaging of DNA in cell nuclei and are associated with DNA transcription, repair, and replication. “We suggest Tax repression of replication-dependent histone gene expression will result in reactivation of viral gene expression, deregulation of cellular gene expression, and genomic instability,” the authors note. “All of these effects may contribute to the development of adult T-cell leukemia/lymphoma.”

    The findings are published online in Retrovirology.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »